Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 26 June 2025
      Rapidly shifting geopolitics provides opportunity for Europe to reset and to lead in global life sciences, says new EFPIA President



Stefan Oelrich, President of Bayer’s Pharmaceuticals Division has been elected as the new President of the European Federation of Pharmaceutical Industries and Associations (EFPIA) with Teresa Graham, CEO of Roche Pharmaceuticals and Carlos Gallardo, Chairman and CEO of Almirall as first and second Vice Presidents.  

Learn more here. 

 
 
      10 years of disclosure

Collaboration between the pharmaceutical industry, healthcare professionals, and patient organisations is fundamental to advancing healthcare and delivering better outcomes for patients. Bringing greater transparency to this already well-regulated and essential relationship builds public understanding and supports long-term collaboration.

That’s why, ten years ago, EFPIA members began disclosing payments to healthcare professionals and organisations.

Explore this blog series to see the progress made and what lies ahead.

 
 
  20 June 2025 A decade of disclosure: Strengthening trust, transparency and collaboration

Strengthening trust, transparency and collaboration

Read more →
 
 
 
  23 June 2025 Putting patients first: why transparency in industry partnerships matters (Guest blog)

Transparent practices help dispel misconceptions, ensure accountability, and demonstrate that collaboration serves shared...

Read more →
 
 
 
  25 June 2025 Disclosure of payments: How transparency works in Spain (Guest blog)

Spain is a leading example of an industry embracing disclosure, building trust and nurturing transparent collaboration...

Read more →
 
 
 
  26 June 2025 Ten years of evolving transparency in industry-healthcare relationships in the UK (Guest blog)...

After a decade of the pharmaceutical industry publicly declaring payments, more health professionals than ever are being...

Read more →
 
 
 
      Events
 
 
22 SEP 2025
  EFPIA Life Sciences Week Brussels

A series of high-level policy discussions on the future of healthcare and innovation in Europe.

Learn more →
 
 
 
10 DEC 2025
  EACH Cardiovascular Health Summit Brussels, Belgium

Save the date for the EACH Cardiovascular Health Summit, taking place on 10–11 December 2025 in Brussels.

Learn more →
 
 
      What we are reading
Collaborating for cardiovascular care 24 June 2025  (IHI) Read more →
Securing Europe’s future in advanced therapies: A policy blueprint from the CEOs of Europe’s... 24 June 2025  (Alliance for Regenerative Medicine) Read more →
What if Europe became a leader in biotech innovation? 16 June 2025  (POLITICO) Read more →
EU long-term budget: Is health funding on the chopping block? 10 June 2025  (Euronews) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
▶ in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe